Rodda Luke N, Farley Megan, Towler Steven, Devincenzi Tyler, Pearring Sue
Forensic Laboratory Division, Office of the Chief Medical Examiner, 1 Newhall St., San Francisco, CA 94124, United States.
Department of Laboratory Medicine, University of California, San Francisco, CA 94143, United States.
J Anal Toxicol. 2025 Jan 20;49(1):1-13. doi: 10.1093/jat/bkae077.
A streamlined LC-MS-MS method utilizing protein precipitation and filtration extraction was developed to consolidate analyses for drug-facilitated crimes (DFCs), postmortem (PM) investigations, and driving under the influence of drug (DUID) testing. Fifty-seven target drug and metabolite analytes eluted in <6 minutes and were compromised of gamma-hydroxybutyric acid precursors (1), hallucinogens (3), muscle relaxants (3), anticonvulsants (7), antidepressants (20), antihistamines (5), antipsychotics (11), antihypertensives and alpha-adrenergics (3), analgesics and anesthetics (3), and miscellaneous (1) in blood (quantitatively) and urine (qualitatively). Limits of detection were set to meet the more challenging sensitivity requirements for DFC and are therefore also suitable for PM investigations and other forensic casework, including DUID. Comprehensive Academy Standards Board / American National Standards Institute (ASB/ANSI) validation was performed, and applicability studies examined 72 proficiency test blood and urine samples, along with 9206 unique blood and urine samples from 5192 authentic forensic cases that resulted in 11,961 positive analytes in samples. By expanding the analytical reach across multiple drug classes through a unified approach and screening a wider number of drugs, the technique can identify substances that might have previously evaded detection, thereby enhancing laboratory efficiency by minimizing the need for multiple tests. When combined with a recently developed in-house method, this integrated testing strategy meets the testing requirements outlined in ASB/ANSI standards and recommendations for DFC, PM, and Tier 1 DUID analyses.
开发了一种采用蛋白质沉淀和过滤萃取的简化液相色谱-串联质谱法,以整合对药物辅助犯罪(DFC)、死后(PM)调查和药物影响下驾驶(DUID)检测的分析。57种目标药物和代谢物分析物在不到6分钟内洗脱出来,包括血液(定量)和尿液(定性)中的γ-羟基丁酸前体(1种)、致幻剂(3种)、肌肉松弛剂(3种)、抗惊厥药(7种)、抗抑郁药(20种)、抗组胺药(5种)、抗精神病药(11种)、抗高血压药和α-肾上腺素能药物(3种)、镇痛药和麻醉药(3种)以及其他(1种)。检测限的设定满足了DFC更具挑战性的灵敏度要求,因此也适用于PM调查和其他法医案件工作,包括DUID。进行了全面的美国国家标准学会/美国国家标准协会(ASB/ANSI)验证,适用性研究检测了72份能力验证血液和尿液样本,以及来自5192例真实法医案件的9206份独特血液和尿液样本,样本中共有11961种阳性分析物。通过统一方法扩大对多种药物类别的分析范围并筛查更多药物,该技术可以识别以前可能未被检测到的物质,从而通过减少多次检测的需求提高实验室效率。当与最近开发的内部方法相结合时,这种综合检测策略满足了ASB/ANSI标准中概述的DFC、PM和一级DUID分析的检测要求。